January 15, 2020
Vascular Medicine Consult Registry Launched for the SVS Vascular Quality Initiative
January 15, 2020—The Society for Vascular Surgery (SVS), the SVS Vascular Quality Initiative (VQI), and the American Heart Association (AHA) announced the introduction of the Vascular Medicine Consult (VMC) registry for the VQI—a collaboration of the SVS Patient Safety Organization (PSO), the Society for Vascular Medicine, and AHA.
The VQI is a joint venture of M2S Inc. and the SVS that collects and analyzes data to improve the quality of vascular care. It is a collaboration between regional groups that use a PSO and the M2S Pathways cloud-based system. Currently, VQI has > 600 facilities and 3,000 physicians participating and > 600,000 vascular procedures reported.
Teaming with the AHA will leverage the strengths of both organizations to improve care delivered to patients with vascular disease in the outpatient populations as well. AHA’s Get With The Guidelines program promotes consistent adherence to evidence-based guidelines in hospital and health care settings across the United States. The collaboration will enable providers to identify the best treatments and medicines to improve quality of life and patient care.
As noted in the announcement, the VMC registry targets the management of new patients who are being treated medically for atherosclerotic carotid artery occlusive disease, abdominal aortic aneurysm, and peripheral lower extremity arterial disease because of atherosclerosis or true aneurysm. The registry will emphasize medication details and dosages, risk factor and lifestyle modifications, nonoperative treatments, and counseling. The registry’s value centers on the comparative effectiveness of surgery versus medically managing patients with vascular diseases. Features include a web-based platform with real-time reporting.
According to the announcement, the new registry uses the M2S Pathways cloud-based platform to provide real-time tracking of patients and outcomes that can be used for quality improvement at a practitioner and institutional level. Outcomes can be evaluated against regional and national benchmarks. In addition, providers have access to a large database for local, regional, and national analysis.
The SVS PSO provides protection against discovery of comparative data in legal proceedings. Providers can submit outcome data in a secure environment because the data will only be used for quality improvement and cannot be publicly reported. Regular audits help ensure data integrity and prevent selective reporting.
Jens Jorgensen, MD, Medical Director of the SVS VQI, commented in the press release, “We are extremely excited about the introduction of the VMC registry. The effort and collaboration put into the VMC will provide a necessary platform for physicians to manage, analyze, and improve outcomes for patients with peripheral arterial disease being treated with medical therapy. Data generated by the registry will directly support our goal of improving care for medically managed patients.”
The VMC steering committee is working to provide scientific expertise and oversight and develop the registry. Randall DeMartino, MD, and Michael R. Jaff, DO, are the cochairs of the steering committee.
In the announcement, Dr. DeMartino commented, “This new registry will allow us to compare the full spectrum of treatment options for patients with vascular disease in order to define the best treatment for each patient.”
Noting that the new registry enables physicians to have a comprehensive view of a patients’ medical profile, Dr. Jaff added, “We can see if we have done enough to keep them healthy. We can understand in greater detail how cardiovascular risk factors are managed and how that impacts patient outcomes.”